Skip to content
2-Day Shipping*
Secure Online Rx
Personalized Treatments
8,750+ Patients
Discreet Shipping
Compounded in the USA
No Surprises, Upfront Pricing
24/7 Provider Messaging
Customized to Your Needs
Same-Day Doctor Visits & Rx
FSA & HSA Eligible
100% Entirely Online
klarnaPay with Klarna

Personalized Compounded Tirzepatide for Weight Management

Personalized compounded tirzepatide is a medication with activity at two hormone receptors involved in metabolic regulation: GIP and GLP-1.

Bodi Envi connects eligible patients with licensed healthcare providers who can evaluate whether an available treatment option is medically appropriate.

Some programs may involve personalized compounded tirzepatide when prescribed by a licensed healthcare provider and permitted under applicable law.

Personalized compounded tirzepatide is not FDA-approved and is not equivalent to an FDA-approved tirzepatide product. Personalized compounded tirzepatide is not regulated by the FDA; compounding pharmacies are regulated by the board of pharmacy for sterile compounding and required to follow US pharmacopeia standards.

Bodi Envi does not manufacture or compound medication.

What Is Personalized Compounded Tirzepatide?

Personalized compounded tirzepatide acts at both:

  • Glucose-dependent insulinotropic polypeptide, or GIP, receptors

  • Glucagon-like peptide-1, or GLP-1, receptors

These pathways are involved in several processes related to metabolism, appetite and glucose regulation.

This dual receptor activity distinguishes personalized compounded tirzepatide from medications that primarily act at GLP-1 receptors alone.

How Does Personalized Compounded Tirzepatide Work?

Personalized compounded tirzepatide activates both GIP and GLP-1 receptors.

These pathways can influence:

  • Appetite

  • Satiety

  • Food intake

  • Insulin response

  • Glucagon regulation

  • Digestion

For some patients, treatment may reduce hunger and make smaller portions feel more satisfying.

Individual responses vary.

What Is GIP?

GIP stands for glucose-dependent insulinotropic polypeptide.

It is a naturally occurring hormone involved in metabolic signaling.

Personalized compounded tirzepatide's activity at both GIP and GLP-1 receptors is one of the primary pharmacologic differences between personalized compounded tirzepatide and semaglutide.

FDA-Approved Tirzepatide Products

Tirzepatide is the active ingredient in FDA-approved prescription medications for specific indications.

Different products and indications have specific prescribing information, warnings and dosing instructions.

Patients should rely on their healthcare provider and official prescribing information when considering treatment.

Personalized Compounded vs FDA-Approved Tirzepatide

Personalized compounded tirzepatide is prepared by a compounding pharmacy when prescribed under applicable circumstances.

Personalized compounded tirzepatide is not FDA-approved.

It has not undergone FDA premarket review for safety, effectiveness or quality.

Personalized compounded tirzepatide should not be represented as a generic version of an FDA-approved tirzepatide product.

It is not equivalent to an FDA-approved tirzepatide product. The FDA does not regulate compounding pharmacies; the board of pharmacy for sterile compounding regulates compounding pharmacies.

Bodi Envi does not manufacture or compound tirzepatide.

Understanding Personalized Compounded Medications

Who May Be Evaluated?

A licensed healthcare provider determines whether a treatment option is appropriate for the patient.

The evaluation may include:

  • Medical history

  • Current medications

  • Weight history

  • Body mass index

  • Weight-related medical conditions

  • Previous treatment

  • Potential contraindications

  • Pregnancy status

  • Individual goals

Completing an assessment does not guarantee treatment. If a patient is not qualified, a full refund is issued.

Learn About Treatment Eligibility

Potential Side Effects

Personalized compounded tirzepatide can cause side effects.

Common gastrointestinal effects reported include:

  • Nausea

  • Diarrhea

  • Vomiting

  • Constipation

  • Abdominal discomfort

Other adverse effects may occur.

Patients should review potential risks and warnings with their healthcare provider.

Learn More About Side Effects or read our Medication Safety page.

Dosing and Monitoring

A prescribing healthcare provider determines the appropriate treatment and dosing plan.

Patients should follow their prescribed instructions and should not increase their dose independently.

Dose changes may depend on treatment response, tolerability and the provider's clinical judgment.

Personalized Compounded Tirzepatide and Nutrition

Reduced appetite can change eating patterns.

Maintaining adequate protein, fluids, fiber and overall nutrition remains important during medical weight management.

Nutrition During Medical Weight Management

Personalized Compounded Tirzepatide and Exercise

Physical activity remains an important part of overall health.

Resistance training may be particularly useful when appropriate for helping support muscle and physical function during weight loss.

Exercise During Medical Weight Management

Program Pricing

Personalized Compounded Tirzepatide programs through Bodi Envi are $175 to $229 per month based on plan. The price is the same at every dose.

Pricing includes:

  • Provider evaluation

  • Medication

  • Supplies

  • Shipping

  • Ongoing provider access

  • Patient support

  • Dose changes

  • GLP-1 ebook and diet plan

See Full Pricing and Plan Terms

The process

How Personalized Compounded Tirzepatide Treatment Works Through Bodi Envi

1

Complete Your Assessment

Provide relevant medical and medication information.

2

Licensed Provider Review

A healthcare provider evaluates your information.

3

Treatment Decision

The provider determines whether treatment is appropriate.

4

Pharmacy Fulfillment

When prescribed, medication is dispensed by VialsRx, a 503A licensed pharmacy.

5

Ongoing Care

Patients have access to appropriate follow-up and treatment monitoring.

Frequently asked questions

Frequently asked questions

Personalized compounded tirzepatide has activity at both GIP and GLP-1 receptors and is often discussed alongside GLP-1 medications.

No. Compounded medications are not reviewed by the FDA. Compounding pharmacies are regulated by the board of pharmacy for sterile compounding.

No. Personalized compounded tirzepatide should not be described as a generic version of an FDA-approved tirzepatide product.

There is no treatment that is automatically best for every patient. The medications have different pharmacology, and a healthcare provider should consider the individual patient's medical circumstances.

No. Bodi Envi does not manufacture or compound medication.

Continue Learning

Start your assessment

Complete a secure online health assessment for review by a licensed healthcare provider.